Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Fluconazole Oral ProductRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Active Trials
0(0%)

Phase Distribution

Not Applicable
1
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Other(1)

Detailed Status

unknown1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown1100%

Recent Activity

0 active trials
Showing 1 of 1
unknownnot_applicable

The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery

NCT03939273

Clinical Trials (1)

Showing 1 of 1 trials
NCT03939273Not Applicable

The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery

Unknown

All 1 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
1